These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 10433957

  • 41. Expression of tumor-associated glycoprotein 72 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Myers RB, Schlom J, Srivastava S, Grizzle WE.
    Mod Pathol; 1995 Apr; 8(3):260-5. PubMed ID: 7617651
    [Abstract] [Full Text] [Related]

  • 42. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z, Wenlv S.
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [Abstract] [Full Text] [Related]

  • 43. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
    Jack GS, Brash AR, Olson SJ, Manning S, Coffey CS, Smith JA, Shappell SB.
    Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
    [Abstract] [Full Text] [Related]

  • 44. Immunoreactivity to caspase-3, caspase-7, caspase-8, and caspase-9 forms is frequently lost in human prostate tumors.
    Rodríguez-Berriguete G, Galvis L, Fraile B, de Bethencourt FR, Martínez-Onsurbe P, Olmedilla G, Paniagua R, Royuela M.
    Hum Pathol; 2012 Feb; 43(2):229-37. PubMed ID: 21802116
    [Abstract] [Full Text] [Related]

  • 45. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA, Truong LD, Rogers E, Kattan M, Flanders KC, Scardino PT, Thompson TC.
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [Abstract] [Full Text] [Related]

  • 46. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
    Liao Y, Abel U, Grobholz R, Hermani A, Trojan L, Angel P, Mayer D.
    Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272
    [Abstract] [Full Text] [Related]

  • 47. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC, Krijtenburg PJ, Rosenberg C, Hop WC, Verkerk AM, Schröder FH, van der Kwast TH, Bosman FT, van Dekken H.
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [Abstract] [Full Text] [Related]

  • 48. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
    Rehman I, Azzouzi AR, Cross SS, Deloulme JC, Catto JW, Wylde N, Larre S, Champigneuille J, Hamdy FC.
    Hum Pathol; 2004 Nov; 35(11):1385-91. PubMed ID: 15668896
    [Abstract] [Full Text] [Related]

  • 49. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
    Wu GJ, Fu P, Chiang CF, Huss WJ, Greenberg NM, Wu MW.
    J Urol; 2005 May; 173(5):1778-83. PubMed ID: 15821586
    [Abstract] [Full Text] [Related]

  • 50. [New insights into the role of estogens and their receptors in prostate cancer].
    Bonkhoff H, Motherby H, Fixemer T.
    Urologe A; 2003 Dec; 42(12):1594-601. PubMed ID: 14668987
    [Abstract] [Full Text] [Related]

  • 51. [Implications of estrogens and their receptors for the development and progression of prostate cancer].
    Bonkhoff H, Fixemer T.
    Pathologe; 2005 Nov; 26(6):461-8. PubMed ID: 16220300
    [Abstract] [Full Text] [Related]

  • 52. The role of estrogens and estrogen receptors in normal prostate growth and disease.
    Prins GS, Korach KS.
    Steroids; 2008 Mar; 73(3):233-44. PubMed ID: 18093629
    [Abstract] [Full Text] [Related]

  • 53. Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study.
    Singh PB, Ragavan N, Ashton KM, Basu P, Nadeem SM, Nicholson CM, Krishna RK, Matanhelia SS, Martin FL.
    Asian J Androl; 2010 Mar; 12(2):203-14. PubMed ID: 19935673
    [Abstract] [Full Text] [Related]

  • 54. The expression of sex steroid receptors and sex steroid-synthesizing/metabolizing enzymes in metastasized lymph nodes of prostate cancer.
    Nakamura Y, Ise K, McNamara KM, Azmahani A, Sato S, Fujishima F, Joh K, Suzuki H, Mitsuzuka K, Arai Y, Takahashi H, Sasano H.
    Hum Pathol; 2019 Feb; 84():124-132. PubMed ID: 30290162
    [Abstract] [Full Text] [Related]

  • 55. Discrepancies between detection of Bcl-2 by in situ hybridization and immunocytochemistry in human prostate cancer tissues.
    Fiorentino M, D'Errico A, Barozzi C, Grigioni WF.
    Int J Cancer; 1998 Dec 18; 79(6):614-8. PubMed ID: 9842970
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Involvement of estrogen receptors in prostatic diseases.
    Kawashima H, Nakatani T.
    Int J Urol; 2012 Jun 18; 19(6):512-22; author reply 522-3. PubMed ID: 22375605
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.